content

Samsung Biologics & STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will...

FDA approves GSKs Advil Dual Action with Acetaminophen for over-the-counter use in the United States

GlaxoSmithKline announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. The exclusive formula...

Catalent Announces Supplying Blueprint Medicines Precision Therapy AYVAKIT

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products,...

Rare Disease Patient Platform Raremark Partners With TriNetX

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced that Raremark, a...

Recipharm names 2019 International Environmental Award winner

Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water...

Signant Health invests for growth with the opening of its new Philadelphia-area office

Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office...

CPhI Japan to be postponed on request of event attendees

CPhI Japan โ€“ organised by Informa Markets โ€“ announces that the event will be postponed until a new date later in the year after...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read